Medi-Tate
Latest round
- Series A
Last raised
- May 2015
Total raised
- $2M
Investors
- 1
About Medi-Tate
Founded in 2007 and headquartered in Hadera, Israel, Medi-Tate Ltd. develops medical devices aimed at treating urological issues. The company was acquired in February 2021 by Olympus Corporation from Xenia Venture Capital and Laborie, Inc. for USD 300 mn.Medi-Tate Ltd. is recognized for the iTind™ procedure, which is a minimally invasive treatment for benign prostatic hyperplasia (BPH). This procedure utilizes a temporary implant that is removed after 5 to 7 days, facilitating rapid symptom relief while preserving sexual and urinary function.'s revenue model is based on the sales of its medical devices, particularly the iTind™ procedure, through B2B transactions with healthcare providers.Following the acquisition in February 2021, Medi-Tate Ltd. aims to leverage the resources of Olympus Corporation to enhance its product development and market presence. The company anticipates expanding the reach of the iTind™ procedure into new geographic markets, particularly targeting additional European regions and increasing its footprint in the United States.
Who invested in Medi-Tate
1 investor across 1 round
See all investors in Medi-Tate
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 5, 2015
Amount
$2M
Investors
Questions about Medi-Tate
Who invested in Medi-Tate?
Medi-Tate has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Medi-Tate raised?
Medi-Tate has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Medi-Tate last raise money?
Medi-Tate's most recent round on record is a Series A, in May 2015.
What does Medi-Tate do?
Founded in 2007 and headquartered in Hadera, Israel, Medi-Tate Ltd.
Where is Medi-Tate headquartered?
Medi-Tate is headquartered in Hadera, Israel.
Which VCs invest in companies like Medi-Tate?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Medi-Tate's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Medi-Tate? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.